Ensem Therapeutics

ENSEM Therapeutics (“ENSEM”) operates from Boston and is a preclinical biopharmaceutical company concentrating on challenging drug targets in oncology. The firm aims to address unmet medical needs by developing high-value therapies. ENSEM represents the fusion of cutting-edge technologies to decode structural ensembles and kinetics for drug development. The organization is committed to pioneering AI-driven structural ensemble and computational drug design, with a vision to bring transformative oncology treatments to patients.